Literature DB >> 28922614

MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections.

Manu Singh1, Yvonne C W Yau2, Shirley Wang1, Valerie Waters3, Ayush Kumar1,4.   

Abstract

In this study, we analyzed 15 multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa from chronic lung infections for expression of 4 different multidrug efflux systems (MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY), using quantitative reverse transcriptase PCR. Overexpression of MexXY pump was observed in all of the isolates tested. Analysis of regulatory genes that control the expression of these 4 efflux pumps revealed a number of previously uncharacterized mutations. Our work shows that MexXY pump overexpression is common in cystic fibrosis isolates and could be contributing to their reduced aminoglycoside susceptibility. Further, we also identified novel mutations in the regulatory genes of the 4 abovementioned Resistance-Nodulation-Division superfamily pumps that may be involved in the overexpression of these pumps.

Entities:  

Keywords:  MexZ; aminoglycoside resistance; mutations de gènes régulateurs; regulatory gene mutations; résistance aux aminoglycosides

Mesh:

Substances:

Year:  2017        PMID: 28922614     DOI: 10.1139/cjm-2017-0380

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  8 in total

1.  Mutations causing low level antibiotic resistance ensure bacterial survival in antibiotic-treated hosts.

Authors:  Jakob Frimodt-Møller; Elio Rossi; Janus Anders Juul Haagensen; Marilena Falcone; Søren Molin; Helle Krogh Johansen
Journal:  Sci Rep       Date:  2018-08-21       Impact factor: 4.379

2.  Interplay between MexAB-OprM and MexEF-OprN in clinical isolates of Pseudomonas aeruginosa.

Authors:  Gertrudis Horna; María López; Humberto Guerra; Yolanda Saénz; Joaquim Ruiz
Journal:  Sci Rep       Date:  2018-11-07       Impact factor: 4.379

3.  Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa.

Authors:  Ye Xu; Xiangkuo Zheng; Weiliang Zeng; Tao Chen; Wenli Liao; Jiao Qian; Jie Lin; Cui Zhou; Xuebin Tian; Jianming Cao; Tieli Zhou
Journal:  Infect Drug Resist       Date:  2020-05-14       Impact factor: 4.003

4.  Survival Comes at a Cost: A Coevolution of Phage and Its Host Leads to Phage Resistance and Antibiotic Sensitivity of Pseudomonas aeruginosa Multidrug Resistant Strains.

Authors:  Sarshad Koderi Valappil; Prateek Shetty; Zoltán Deim; Gabriella Terhes; Edit Urbán; Sándor Váczi; Roland Patai; Tamás Polgár; Botond Zsombor Pertics; György Schneider; Tamás Kovács; Gábor Rákhely
Journal:  Front Microbiol       Date:  2021-12-02       Impact factor: 5.640

5.  Aminoglycoside-Modifying Enzymes Are Sufficient to Make Pseudomonas aeruginosa Clinically Resistant to Key Antibiotics.

Authors:  Aswin Thacharodi; Iain L Lamont
Journal:  Antibiotics (Basel)       Date:  2022-07-01

6.  ClpV3 of the H3-Type VI Secretion System (H3-T6SS) Affects Multiple Virulence Factors in Pseudomonas aeruginosa.

Authors:  Yanqi Li; Lin Chen; Pansong Zhang; Anjali Y Bhagirath; Kangmin Duan
Journal:  Front Microbiol       Date:  2020-05-29       Impact factor: 5.640

7.  Characterizations of the viability and gene expression of dispersal cells from Pseudomonas aeruginosa biofilms released by alginate lyase and tobramycin.

Authors:  Said M Daboor; Renee Raudonis; Zhenyu Cheng
Journal:  PLoS One       Date:  2021-10-25       Impact factor: 3.240

8.  The LysR-Type Transcriptional Regulator BsrA (PA2121) Controls Vital Metabolic Pathways in Pseudomonas aeruginosa.

Authors:  Magdalena Modrzejewska; Adam Kawalek; Aneta Agnieszka Bartosik
Journal:  mSystems       Date:  2021-07-13       Impact factor: 6.496

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.